Deutsche Bank analyst Pito Chickering lowered the firm’s price target on Acadia Healthcare (ACHC) to $20 from $33 and keeps a Buy rating on the shares. The company in a regulatory filing reduced its 2025 EBITDA guidance by 7.5% due to a $49M increase in its expectations for 2025 professional and general liability reserves expense, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACHC:
- Acadia Healthcare Stock (ACHC) Plunges on Guidance Cut
- Closing Bell Movers: Marvell up 11%, reversing initial earnings selloff
- Acadia Healthcare down 24% at $12.50 after cutting FY25 guidance
- Acadia Healthcare cuts FY 25 EPS view to $1.94-$2.04 from $2.35-$2.45
- Acadia Healthcare Updates 2025 Fiscal Year Guidance